Human Osteopontin Ready-To-Use IHC Kit Size:50 Test Expression of Periostin is increased

Expression of Periostin is increased by bone morphogenetic protein (BMP2) and transforming growth factor beta 1(TGF beta 1)

is characterized by abnormal filamentous protein deposits in the brain

PCNA is a potentially useful marker of cells with proliferative potential and for identifying the proliferation status of tumor tissue (i

: IHC0245R

BiossPMTM Rainbow Protein Markers are designed for monitoring protein separation during SDS-polyacrylamide gel electrophoresis

Human Osteopontin Ready-To-Use IHC Kit Size:50 Test Expression of Periostin is increasedHuman Osteopontin Ready To Use IHC Kit Cat. No.: IHC0343H Sample Type: FFPE tissue Size: 50T (including a control slide) Storage and Stability: Please store components at the temperatures indicated on the individual tube labels. The kit is stable for 6 months from the date of receipt. Background Osteopontin is an arginine glycine aspartic acid (RGD) containing glycoprotein that interacts with integrins and CD44 as major receptors. It is a